Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply.
Shah SA, Amarikwa L, Sears CM, Clauss KD, Rajjoub RD, Kang JY, Tamhankar MA, Briceño CA, Harrison AR, Cockerham KP, Wester ST, Douglas RS, Dosiou C, Kossler AL. Shah SA, et al. Among authors: harrison ar. Ophthalmology. 2024 Feb 12:S0161-6420(24)00003-4. doi: 10.1016/j.ophtha.2024.01.003. Online ahead of print. Ophthalmology. 2024. PMID: 38349298 No abstract available.
Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multicenter Study.
Shah SA, Amarikwa L, Sears CM, Clauss KD, Rajjoub RD, Kang JY, Tamhankar MA, Briceño CA, Harrison AR, Dosiou C, Cockerham KP, Wester ST, Douglas RS, Kossler AL. Shah SA, et al. Among authors: harrison ar. Ophthalmology. 2024 Apr;131(4):458-467. doi: 10.1016/j.ophtha.2023.10.018. Epub 2023 Oct 16. Ophthalmology. 2024. PMID: 37852417
Anaplastic Meningioma of the Orbit.
Rajjoub RD, Venteicher AS, Harrison AR. Rajjoub RD, et al. Among authors: harrison ar. Ophthalmology. 2024 Apr;131(4):444. doi: 10.1016/j.ophtha.2023.05.033. Epub 2023 Jun 26. Ophthalmology. 2024. PMID: 37367702 No abstract available.
Teprotumumab for the treatment of chronic thyroid eye disease.
Ugradar S, Kang J, Kossler AL, Zimmerman E, Braun J, Harrison AR, Bose S, Cockerham K, Douglas RS. Ugradar S, et al. Among authors: harrison ar. Eye (Lond). 2022 Aug;36(8):1553-1559. doi: 10.1038/s41433-021-01593-z. Epub 2021 Jul 9. Eye (Lond). 2022. PMID: 34244669 Free PMC article.
Outcomes of Patients With Thyroid Eye Disease Partially Treated With Teprotumumab.
Ho TC, Maamari RN, Kossler AL, Sears CM, Freitag SK, Reshef ER, Shinder R, Rootman DB, Diniz SB, Kahana A, Schlachter D, Do TH, Kally P, Turner S, Mokhtarzadeh A, Harrison AR, Hwang CJ, Kim HJ, Avila SA, Thomas DA, Magazin M, Wester ST, Lee WW, Clauss KD, Holds JB, Sniegowski M, Compton CJ, Briggs C, Malik AI, Lucarelli MJ, Burkat CN, Patel LG, Couch SM. Ho TC, et al. Among authors: harrison ar. Ophthalmic Plast Reconstr Surg. 2023 Mar-Apr 01;39(2):150-155. doi: 10.1097/IOP.0000000000002267. Epub 2022 Sep 9. Ophthalmic Plast Reconstr Surg. 2023. PMID: 36095848 Free PMC article.
148 results